CH AllergyIntolerance (R4)
3.0.0 - trial-use
This page is part of the CH-AllergyIntolerance (R4) (v3.0.0: STU 3) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "AllergyIntolerance",
"id" : "CH-AllergyIntolerance-Usecase-2",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AllergyIntolerance CH-AllergyIntolerance-Usecase-2</b></p><a name=\"CH-AllergyIntolerance-Usecase-2\"> </a><a name=\"hcCH-AllergyIntolerance-Usecase-2\"> </a><a name=\"CH-AllergyIntolerance-Usecase-2-en-US\"> </a><p><b>Abatement</b>: 2022-02-07</p><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification unconfirmed}\">Unconfirmed</span></p><p><b>type</b>: Allergy</p><p><b>category</b>: Medication</p><p><b>criticality</b>: Low Risk</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 860765003}\">Allergy to thiazide (finding)</span></p><p><b>patient</b>: <a href=\"Patient-ElisabethBroennimannByBFH.html\">Elisabeth Brönnimann-Bertholet Female, DoB: 1937-05-03</a></p><h3>Reactions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Substance</b></td><td><b>Manifestation</b></td><td><b>Severity</b></td><td><b>ExposureRoute</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 387525002}\">Hydrochlorothiazide (substance)</span></td><td><span title=\"Codes:{http://snomed.info/sct 126485001}\">Urticaria (disorder)</span></td><td>Moderate</td><td><span title=\"Codes:{http://snomed.info/sct 26643006}\">Oral route (qualifier value)</span></td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/allergyintolerance-abatement",
"valueDateTime" : "2022-02-07"
}
],
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
"code" : "active",
"display" : "Active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
"code" : "unconfirmed",
"display" : "Unconfirmed"
}
]
},
"type" : "allergy",
"category" : [
"medication"
],
"criticality" : "low",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "860765003",
"display" : "Allergy to thiazide (finding)"
}
]
},
"patient" : {
🔗 "reference" : "Patient/ElisabethBroennimannByBFH"
},
"reaction" : [
{
"substance" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "387525002",
"display" : "Hydrochlorothiazide (substance)"
}
]
},
"manifestation" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "126485001",
"display" : "Urticaria (disorder)"
}
]
}
],
"severity" : "moderate",
"exposureRoute" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "26643006",
"display" : "Oral route (qualifier value)"
}
]
}
}
]
}